PFBT
IMVT icon

Parkside Financial Bank & Trust’s Immunovant IMVT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43K Hold
63
– – ﹤0.01% 2119
2026
Q1 		$1.56K Hold
63
– – ﹤0.01% 2204
2025
Q4 		$1.6K Hold
63
– – ﹤0.01% 2178
2025
Q3 		$1.02K Hold
63
– – ﹤0.01% 2281
2025
Q2 		$1.01K Buy
+63
New +$953 ﹤0.01% 2269

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parkside Financial Bank & Trust's IMVT Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Immunovant (IMVT) position steady in Q2 2026 at 63 shares worth $2.43K. The position accounts for ﹤0.01% of the portfolio, ranked #2119.

Parkside Financial Bank & Trust first reported a position in IMVT in Q2 2025 and has held it in 5 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Parkside Financial Bank & Trust held 63 shares of Immunovant worth $2.43K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2119 holding.
  • Parkside Financial Bank & Trust first reported a position in Immunovant in Q2 2025 and has held it in 5 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.